AZ Rivierenland
- Address
- lock Available on a paid plan
Anesthesiology and Surgical Pain Management
At AZ Rivierenland in Rumst, clinical research in anesthesiology focuses on improving pain control and recovery after surgery, especially for patients scheduled for shoulder operations and inguinal hernia repair. These studies are designed to test better ways to relieve postoperative pain and support smoother healing.
- Evaluating perineural dexmedetomidine to extend pain relief after an interscalene plexus block
- Comparing TAP block with local wound infiltration for laparoscopic inguinal hernia surgery
- Assessing locoregional techniques to improve postoperative analgesia
Overall, this research area centers on finding more effective analgesic strategies that can reduce discomfort and improve patient experience after operative procedures.
Digestive System Cancer Research
The site also supports studies in digestive system diseases, with a strong focus on colon cancer. One major line of research examines whether acetylsalicylic acid can improve survival and reduce recurrence in patients with stage II and III disease, reflecting interest in better long-term treatment options.
- Studying colon carcinoma outcomes after surgery
- Testing whether aspirin can improve overall survival in colon cancer
- Exploring approaches to lower the risk of cancer recurrence
This work aims to evaluate treatment effectiveness and help define supportive strategies for people living with colorectal cancer.
Neuroendocrine Tumour Treatment Strategies
Research in neoplasms at AZ Rivierenland includes studies in neuroendocrine tumours, where investigators are examining how ongoing treatment can be managed when the disease progresses. The purpose is to better understand whether continuing or stopping standard therapy may influence patient outcomes and quality of life.
- Investigating treatment choices after progression in neuroendocrine tumour patients
- Assessing survival and symptom-related outcomes during second-line therapy
- Looking at patient well-being alongside disease control
These studies combine oncology and patient-reported outcomes to guide more personalized care for people with advanced neuroendocrine cancer.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1Algemeen ziekenhuis Rivierenland1active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Algemeen ziekenhuis Rivierenland2trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 307 other sites in Belgium
Therapeutic Area Benchmark — Belgium
Select a therapeutic area to compare against other sites in Belgium.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Belgium
Market Share
Country: Belgium
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in AZ Rivierenland
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Continuing Somatostatin Analogues Upon progression in Neuroendocrine tumour pAtients (SAUNA trial) | Universitair Ziekenhuis Antwerpen | Phase III | Recruiting | Jun 2023 | — |
IMP list
lock Showing 1 of 14 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ropivacaine Hydrochloride | 3 | Unknown | 2024-01-02 | 2025-05-13 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.